|
Device
|
Applicant
|
PMA Number
|
Decision Date
|
VENTANA PD-L1(SP142) CDX ASSAY
|
VENTANA MEDICAL SYSTEMS, INC. |
P160002 S001 |
12/21/2016 |
PD-L1 IHC 22C3 PHARMDX
|
Agilent Technologies, Inc. |
P150013 S003 |
12/01/2016 |
PD-L1 IHC 28-8 PHARMDX (Non-Squamous Indication)
|
Agilent Technologies, Inc. |
P150025 S002 |
12/01/2016 |
PD-L1 IHC 28-8 PHARMDX (Melanoma Indication)
|
DAKO NORTH AMERICA, INC. |
P150027 S002 |
12/01/2016 |
PD-L1 IHC 22C3 PHARMDX
|
Agilent Technologies, Inc. |
P150013 S001 |
10/24/2016 |
VENTANA PD-L1 (SP142) Assay
|
VENTANA MEDICAL SYSTEMS, INC. |
P160006 |
10/18/2016 |
PD-L1 IHC 28-8 PHARMDX (NON-SQUAMOUS NSCLC INDICAT...
|
Agilent Technologies, Inc. |
P150025 S001 |
10/05/2016 |
PD-L1 IHC 28-8 PHARMDX (MELANOMA INDICATION)
|
DAKO NORTH AMERICA, INC. |
P150027 S001 |
10/05/2016 |
PD-L1 IHC 22C3 PHARMDX
|
Agilent Technologies, Inc. |
P150013 S002 |
09/23/2016 |
VENTANA PD-L1(SP142) CDX ASSAY
|
VENTANA MEDICAL SYSTEMS, INC. |
P160002 |
05/18/2016 |